Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sarepta Therapeutics, Inc. | 201,983 | reported | 11 Mar 2026 | tx 65+461,295−131,460 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2026 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 1,097 | 17.03 USD | |
| 09 Mar 2026 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 1,036 | 16.95 USD | |
| 09 Mar 2026 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 583 | 16.95 USD | |
| 02 Mar 2026 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 875 | 16.20 USD | |
| 02 Mar 2026 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 3,301 | 16.20 USD | |
| 01 Mar 2026 | EXERCISE | Sarepta Therapeutics, Inc. | 8,125 | — | |
| 01 Mar 2026 | EXERCISE | Sarepta Therapeutics, Inc. | 8,125 | 0.00 USD | deriv |
| 26 Feb 2026 | EXERCISE | Sarepta Therapeutics, Inc. | 2,069 | 13.71 USD | |
| 26 Feb 2026 | EXERCISE | Sarepta Therapeutics, Inc. | 5,381 | 13.71 USD | |
| 26 Feb 2026 | EXERCISE | Sarepta Therapeutics, Inc. | 5,381 | 0.00 USD | deriv |
| 26 Feb 2026 | EXERCISE | Sarepta Therapeutics, Inc. | 2,069 | 0.00 USD | deriv |
| 25 Feb 2026 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 1,875 | — | deriv |
| 16 Dec 2025 | SALE | Sarepta Therapeutics, Inc. | 13,187 | 22.31 USD | |
| 03 Sept 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 50,000 | 0.00 USD | |
| 03 Sept 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 93,875 | 0.00 USD | |
| 05 Aug 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 6,250 | 0.00 USD | deriv |
| 07 Mar 2025 | EXERCISE | Sarepta Therapeutics, Inc. | 5,500 | — | |
| 10 Mar 2025 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 1,051 | 100.13 USD | |
| 10 Mar 2025 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 2,890 | 100.13 USD | |
| 10 Mar 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 8,276 | — | |
| 07 Mar 2025 | EXERCISE | Sarepta Therapeutics, Inc. | 5,500 | 0.00 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 16,644 | 0.00 USD | deriv |
| 07 Mar 2025 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 585 | 103.70 USD | |
| 06 Mar 2025 | EXERCISE | Sarepta Therapeutics, Inc. | 17,500 | — | |
| 07 Mar 2025 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 9,094 | 103.70 USD |